{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:49:07Z","timestamp":1770749347863,"version":"3.50.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10461-021-03512-5","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T05:02:30Z","timestamp":1635829350000},"page":"1597-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-6000","authenticated-orcid":false,"given":"Juliane","family":"Etima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana W. K.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Duby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaveni","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mathebula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chifundo","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila E.","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmah","family":"Manengamambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Soto-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth T.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the MTN-020\/ASPIRE, MTN 025\/HOPE, MTN-032 Study teams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"3512_CR1","unstructured":"UNAIDS D. Update AE. Geneva: Joint United Nations Programme on HIV. AIDS. 2019."},{"issue":"1","key":"3512_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12889-017-4959-3","volume":"17","author":"R Eakle","year":"2017","unstructured":"Eakle R, Bourne A, Jarrett C, Stadler J, Larson H. Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography. BMC Public Health. 2017;17(1):968.","journal-title":"BMC Public Health"},{"issue":"22","key":"3512_CR3","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"issue":"6","key":"3512_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"3512_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5","key":"3512_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334.","journal-title":"N Engl J Med"},{"issue":"9883","key":"3512_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"issue":"2","key":"3512_CR8","doi-asserted-by":"publisher","first-page":"e89118","DOI":"10.1371\/journal.pone.0089118","volume":"9","author":"A van der Straten","year":"2014","unstructured":"van der Straten A, Stadler J, Montgomery E, Hartmann M, Magazi B, Mathebula F, et al. Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PloS One. 2014;9(2):e89118.","journal-title":"PloS One"},{"key":"3512_CR9","first-page":"29","volume":"22","author":"J Baeten","year":"2019","unstructured":"Baeten J, Palanee-Phillips T, Mgodi N, Ramjee G, Gati B, Mhlanga F, et al. High adherence and sustained impact on HIV-1 incidence: final results of an open-label extension trial of the dapivirine vaginal ring. J Int AIDS Soc. 2019;22:29.","journal-title":"J Int AIDS Soc"},{"key":"3512_CR10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121.","journal-title":"N Engl J Med"},{"issue":"3","key":"3512_CR11","doi-asserted-by":"publisher","first-page":"e0147743","DOI":"10.1371\/journal.pone.0147743","volume":"11","author":"A Nel","year":"2016","unstructured":"Nel A, Bekker L-G, Bukusi E, Hellstr\u04e7m E, Kotze P, Louw C, et al. Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa. PloS One. 2016;11(3):e0147743.","journal-title":"PloS One"},{"key":"3512_CR12","volume-title":"European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings. Geneva: WHO; 2020."},{"issue":"7","key":"3512_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s10461-015-1088-9","volume":"20","author":"K Underhill","year":"2016","unstructured":"Underhill K, Morrow KM, Colleran C, Calabrese SK, Operario D, Salovey P, et al. Explaining the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention: a qualitative study of message framing and messaging preferences among US men who have sex with men. AIDS Behav. 2016;20(7):1514\u201326.","journal-title":"AIDS Behav"},{"issue":"3","key":"3512_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/QAI.0b013e31822b76d2","volume":"58","author":"BA Koblin","year":"2011","unstructured":"Koblin BA, Mansergh G, Frye V, Tieu HV, Hoover DR, Bonner S, et al. Condom-use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: project MIX. JAIDS J Acquir Immun Defic Syndr. 2011;58(3):319\u201327.","journal-title":"JAIDS J Acquir Immun Defic Syndr"},{"issue":"11","key":"3512_CR15","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1097\/QAD.0000000000001868","volume":"32","author":"ET Montgomery","year":"2018","unstructured":"Montgomery ET, Stadler J, Naidoo S, Katz AW, Laborde N, Garcia M, et al. Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS. 2018;32(11):1517\u201325.","journal-title":"AIDS"},{"issue":"3","key":"3512_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10461-011-0027-7","volume":"16","author":"C Woodsong","year":"2012","unstructured":"Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, et al. Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS Behav. 2012;16(3):785\u201390.","journal-title":"AIDS Behav"},{"key":"3512_CR17","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s10461-020-02799-0","volume":"24","author":"AW Katz","year":"2020","unstructured":"Katz AW, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, et al. The power of the shared experience: MTN-020\/ASPIRE trial participants\u2019 descriptions of peer influence on acceptability of and adherence to the dapivirine vaginal ring for HIV prevention. AIDS Behav. 2020;24:2387.","journal-title":"AIDS Behav"},{"issue":"5","key":"3512_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10461-010-9806-9","volume":"15","author":"ET Montgomery","year":"2011","unstructured":"Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women\u2019s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2011;15(5):959\u201369.","journal-title":"AIDS Behav"},{"issue":"5","key":"3512_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","volume":"19","author":"ET Montgomery","year":"2015","unstructured":"Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, et al. Male partner influence on women\u2019s HIV prevention trial participation and use of pre-exposure prophylaxis: the importance of \u201cunderstanding.\u201d AIDS Behav. 2015;19(5):784\u201393.","journal-title":"AIDS Behav"},{"issue":"11","key":"3512_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/13691058.2018.1552989","volume":"21","author":"M Chitukuta","year":"2019","unstructured":"Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T, et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Cult Health Sex. 2019;21(11):1209\u201324.","journal-title":"Cult Health Sex"},{"issue":"9","key":"3512_CR21","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1007\/s10461-014-0771-6","volume":"18","author":"RC Dellar","year":"2014","unstructured":"Dellar RC, Karim QA, Mansoor LE, Grobler A, Humphries H, Werner L, et al. The preventive misconception: experiences from CAPRISA 004. AIDS Behav. 2014;18(9):1746\u201352.","journal-title":"AIDS Behav"},{"issue":"12","key":"3512_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/medethics-2012-100821","volume":"39","author":"MA Ott","year":"2013","unstructured":"Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD, the Adolescent Medicine Trials Network (ATN). Preventive misconception and adolescents\u2019 knowledge about HIV vaccine trials. J Med Ethics. 2013;39(12):765\u201371.","journal-title":"J Med Ethics"},{"issue":"2","key":"3512_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jadohealth.2014.01.006","volume":"55","author":"M Lally","year":"2014","unstructured":"Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, et al. Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials. J Adolesc Health. 2014;55(2):254\u20139.","journal-title":"J Adolesc Health"},{"issue":"1","key":"3512_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/13691058.2010.511270","volume":"13","author":"J Stadler","year":"2011","unstructured":"Stadler J, Saethre E. Blockage and flow: intimate experiences of condoms and microbicides in a South African clinical trial. Cult Health Sex. 2011;13(1):31\u201344.","journal-title":"Cult Health Sex"},{"issue":"4","key":"3512_CR25","doi-asserted-by":"publisher","first-page":"e033849","DOI":"10.1136\/bmjopen-2019-033849","volume":"10","author":"I Young","year":"2020","unstructured":"Young I, Valiotis G. Strategies to support HIV literacy in the roll-out of pre-exposure prophylaxis in Scotland: findings from qualitative research with clinical and community practitioners. BMJ Open. 2020;10(4):e033849.","journal-title":"BMJ Open"},{"issue":"16","key":"3512_CR26","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","volume":"29","author":"A van der Straten","year":"2015","unstructured":"van der Straten A, Montgomery ET, Musara P, Etima J, Naidoo S, Laborde N, et al. Disclosure of pharmacokinetic drug results to understand nonadherence: results from a qualitative study. AIDS (London, England). 2015;29(16):2161.","journal-title":"AIDS (London, England)"},{"issue":"1","key":"3512_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/17290376.2018.1536561","volume":"15","author":"C Rubincam","year":"2018","unstructured":"Rubincam C, Newman PA, Atujuna M, Bekker L-G. \u2018Why would you promote something that is less percent safer than a condom?\u2019: Perspectives on partially effective HIV prevention technologies among key populations in South Africa. SAHARA-J J Soc Asp HIV\/AIDS. 2018;15(1):179.","journal-title":"SAHARA-J J Soc Asp HIV\/AIDS"},{"issue":"1","key":"3512_CR28","first-page":"1","volume":"1","author":"EE Tarkang","year":"2015","unstructured":"Tarkang EE, Zotor FB. Application of the Health Belief Model (HBM) in HIV prevention: a literature review. Central Afr J Public Health. 2015;1(1):1\u20138.","journal-title":"Central Afr J Public Health"},{"key":"3512_CR29","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1188\/18.ONF.508-526","volume":"45","author":"VK Marshall","year":"2018","unstructured":"Marshall VK, Given BA. Factors associated with medication beliefs in patients with cancer: an integrative review. Oncol Nurs Forum. 2018;45:508.","journal-title":"Oncol Nurs Forum"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03512-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03512-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T19:33:55Z","timestamp":1649705635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03512-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3512"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03512-5","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"15 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The primary author implemented the study at the Kampala-Uganda site as the Investigator of Record through the Microbicide Trials Network (MTN). The study was funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The primary author received salary support during the implementation of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved at the various study sites by all regulatory\/ethics committees in each respective country. At Makerere University-Johns Hopkins University (MUJHU) in Uganda where the primary author conducted the study, ethical approval was received from Joint Clinical Research (JCRC) ethics review committee, Uganda National Council for Science and Technology (UNCST) and Johns Hopkins Medicine IRB. All study participants were consented for participation in the study, dissemination and publication of the study findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}